[go: up one dir, main page]

NO984166D0 - Sekvenskombinasjon av östrogen/progesteronantagonister for hormonerstatningsterapi - Google Patents

Sekvenskombinasjon av östrogen/progesteronantagonister for hormonerstatningsterapi

Info

Publication number
NO984166D0
NO984166D0 NO984166A NO984166A NO984166D0 NO 984166 D0 NO984166 D0 NO 984166D0 NO 984166 A NO984166 A NO 984166A NO 984166 A NO984166 A NO 984166A NO 984166 D0 NO984166 D0 NO 984166D0
Authority
NO
Norway
Prior art keywords
replacement therapy
hormone replacement
estrogen
sequence combination
progesterone antagonists
Prior art date
Application number
NO984166A
Other languages
English (en)
Other versions
NO324613B1 (no
NO984166L (no
Inventor
Kristof Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO984166D0 publication Critical patent/NO984166D0/no
Publication of NO984166L publication Critical patent/NO984166L/no
Publication of NO324613B1 publication Critical patent/NO324613B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO19984166A 1996-03-11 1998-09-10 Anvendelse av en sekvenskombinasjon av ostrogen/progesteronantagonister for fremstilling av et legemiddel for hormonerstatningsterapi NO324613B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19610635A DE19610635A1 (de) 1996-03-11 1996-03-11 Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie
PCT/DE1997/000580 WO1997033589A1 (de) 1996-03-11 1997-03-11 Sequentielle estrogen/progesteronantagonist-kombination für die hormonersatz-therapie

Publications (3)

Publication Number Publication Date
NO984166D0 true NO984166D0 (no) 1998-09-10
NO984166L NO984166L (no) 1998-09-10
NO324613B1 NO324613B1 (no) 2007-11-26

Family

ID=7788657

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984166A NO324613B1 (no) 1996-03-11 1998-09-10 Anvendelse av en sekvenskombinasjon av ostrogen/progesteronantagonister for fremstilling av et legemiddel for hormonerstatningsterapi

Country Status (16)

Country Link
EP (1) EP0889727B1 (no)
JP (1) JP2000506175A (no)
KR (1) KR19990087672A (no)
AT (1) ATE319454T1 (no)
AU (1) AU2691197A (no)
BR (1) BR9708162A (no)
CA (1) CA2248841C (no)
DE (2) DE19610635A1 (no)
DK (1) DK0889727T3 (no)
ES (1) ES2260792T3 (no)
HU (1) HUP9901474A3 (no)
IL (1) IL126176A (no)
NO (1) NO324613B1 (no)
PL (1) PL328809A1 (no)
PT (1) PT889727E (no)
WO (1) WO1997033589A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834931A1 (de) * 1998-07-28 2000-02-24 Jenapharm Gmbh Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
US7629334B1 (en) 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
AU781836B2 (en) * 1999-08-31 2005-06-16 Schering Aktiengesellschaft Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (HRT)
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist/antagonist for the manufacture of a medicament for treating vaginitis
ATE288303T1 (de) * 2000-11-30 2005-02-15 Pfizer Prod Inc Östrogen agonist-antagonist und testosteron enthaltende zusammensetzung zur behandlung abnehmender testosteronspiegel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy

Also Published As

Publication number Publication date
KR19990087672A (ko) 1999-12-27
PT889727E (pt) 2006-07-31
IL126176A (en) 2004-12-15
PL328809A1 (en) 1999-02-15
CA2248841A1 (en) 1997-09-18
DE19610635A1 (de) 1997-09-18
NO324613B1 (no) 2007-11-26
DK0889727T3 (da) 2006-07-03
ATE319454T1 (de) 2006-03-15
BR9708162A (pt) 1999-07-27
CA2248841C (en) 2008-07-22
AU2691197A (en) 1997-10-01
EP0889727A1 (de) 1999-01-13
DE59712593D1 (de) 2006-05-04
JP2000506175A (ja) 2000-05-23
ES2260792T3 (es) 2006-11-01
IL126176A0 (en) 1999-05-09
HUP9901474A2 (hu) 1999-09-28
HUP9901474A3 (en) 2000-02-28
WO1997033589A1 (de) 1997-09-18
NO984166L (no) 1998-09-10
EP0889727B1 (de) 2006-03-08

Similar Documents

Publication Publication Date Title
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
FI970260A7 (fi) Progesteroniantagonisti ja gestageeni endometrioosin ja leiomyomata uterin hoitamiseksi
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
NL300381I2 (nl) Estradiolvaleraat en dienogest
EP1028715A4 (en) FORMULATION FOR NASAL SUPPORT AND METHOD OF USE THEREOF
DK1001772T3 (da) Forbedret afgivelse af flere doser af et medikament
BR9609645A (pt) Inalador para a administração de medicamentos a partir de embalagens de ampola
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
CO5261567A1 (es) Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas
GB2305606B (en) Drug delivery composition for the nasal administration of ICAM-1
NO984166D0 (no) Sekvenskombinasjon av östrogen/progesteronantagonister for hormonerstatningsterapi
BG101427A (en) Competitive progesterone antagonists for regulating female fertility as required
PL348202A1 (en) Pharmaceutically active composition and dispensing device
DE60025264D1 (de) Dosierbehälter für pulverförmige medikamente
JP2001513566A5 (no)
DE50005282D1 (de) Medikament sowie aufeinander abgestimmte kombination von medikamenten
ATE212352T1 (de) Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische präparate
BR9912260A (pt) Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração
MX9704527A (es) Sistema transdermico de administracion simultanea de varios principios activos.
ECSP003721A (es) Una composicion farmaceutica para ser usada como anticonceptivo
MX9605190A (es) Forma de dosis efectiva para farmacos antiepilepticos.